Tumour suppression by immune system through stochastic oscillations

Journal of Theoretical Biology

Volumn 265, Issue 3, 2010, Pages 336-345

  Caravagna, Giulio ^a   d'Onofrio, Alberto ^b   Milazzo, Paolo ^a   Barbuti, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Immune surveillance; Immune system; Immunotherapy; Stochastic Hybrid; Tumour

Indexed keywords

IMMUNE SYSTEM; IMMUNIZATION; MODELING; STOCHASTICITY; TUMOR;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; HYBRID; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; OSCILLATION; PRIORITY JOURNAL; STOCHASTIC MODEL; TUMOR IMMUNITY; ALGORITHM; BIOLOGICAL MODEL; BIOLOGICAL RHYTHM; COMPUTER SIMULATION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; PROCEDURES; STATISTICS;

ALGORITHMS; BIOLOGICAL CLOCKS; COMPUTER SIMULATION; HUMANS; IMMUNOTHERAPY; MODELS, IMMUNOLOGICAL; NEOPLASMS; STOCHASTIC PROCESSES;

EID: 77954622036     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.05.013     Document Type: Article

References (47)

1. Agarwala, S.A., 2003. New applications of cancer immunotherapy, Agarwala, S.A. (Ed.), Seminars in Oncology, Special Issue 29-3 (Suppl. 7).
2. Alfonsi, A., Cances, E., Turinici, G., Di Ventura, B., Huisiga, W., 2004. Exact simulation of hybrid stochastic and deterministic models for biochemical systems. INRIA Technical Report 5435.
3. Anderson D.F. A modified next reaction method for simulating chemical systems with time dependent propensities and delays. J. Chem. Phys. 2007, 127:214107.
4. Bellomo N., Delitala M. From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells. Phys. Life Rev. 2008, 5:183-206.
5. Bellomo N., Li N.K., Maini P.K. On the foundations of cancer modelling: selected topics, speculations, and perspectives. Math. Models Methods Appl. Sci. 2008, 18:593-646.
6. Bleumer I., Oosterwijk E., de Mulder P., Mulders P.F. Immunotherapy for renal cell carcinoma. European Urology 2003, 44:65-75.
7. Blumberg N., Chuang-Stein C., Heal J.M. The relationship of blook transfusion, tumor staging, and cancer recurrence. Transfusion 1990, 30(4):291-294.
8. Burnet F.M. Cancer-a biological approach. Br. Med. J. 1957, 1:841-847.
9. Cappuccio A., Elishmereni M., Agur Z. Cancer immunotherapy by interleukin-21 treatment strategies evaluated in a mathematical model. Cancer Res. 2006, 66:7293-7300.
10. Cattani, C., Ciancio, A., d'Onofrio, A. 2010. Metamodeling the learning-hiding competition between tumours and the immune system: a kinematic approach. Math. Comput. Modelling 52, 62-69.
11. DeBoer R.J., Hogeweg P., Hub F., Dullens J., DeWeger R.A., DenOtter W. Macrophage T Lymphocyte interactions in the anti-tumor immune response: a mathematical model. J. Immunol. 1985, 134:2748-2758.
12. De Lisi C., Rescigno A. Immune surveillance and neoplasia: a minimal mathematical model. Bull. Math. Biol. 1977, 39(2):201-221.
13. De Pillis L.G., Radunskaya A.E., Wiseman C.L. A validated mathematical model of cell-mediated immune response to tumour growth. Cancer Res. 2005, 65:7950-7958.
14. De Vita Jr.V.T., Hellman, S., Rosenberg, S.A., 2008. Cancer: principles and practice of oncology, eight ed. Lippincott Williams & Wilkins.
15. De Vladar H.P., Gonzalez J.A. Dynamic response of cancer under the influence of immunological activity and therapy. J. Theor. Biol. 2004, 227:335-348.
16. d'Onofrio A., Gatti F., Cerrai P. Delay-induced oscillatory dynamics of tumour-immune system interaction. Math. Comput. Modelling 2010, 51:572-591.
17. d'Onofrio A. Tumour evasion from immune system control: strategies of a MISS to become a MASS. Chaos Solitons Fractals 2007, 31:261-268.
18. d'Onofrio A. A general framework for modeling tumour-immune system competition and immunotherapy: mathematical analysis and biomedical inferences. Phys. D 2005, 208:220-235.
19. d'Onofrio A. Tumour-immune system interaction: modeling the tumour-stimulated proliferation of effectors and immunotherapy. Math. Models Methods Appl. Sci. 2006, 16:1375-1401.
20. Dunn G.P., Old L.J., Schreiber R.D. The three ES of cancer immunoediting. Ann. Rev. Immunol. 2004, 22:322-360.
21. Ehrlich P. Ueber den jetzigen Stand der Karzinomforschung. Ned. Tijdschr. Geneeskd. 1909, 5:273-290.
22. Galach M. Dynamics of the tumour-immune system competition: the effect of time delay. Int. J. Appl. Math. Comput. Sci. 2003, 13:395-406.
23. Gatti R., et al. Cyclic leukocytosis in chronic myelogenous leukemia: new perspectives on pathogenesis and therapy. Blood 1973, 41:771-783.
24. Gillespie D. Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 1977, 81:2340-2361.
25. Gillespie D. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J. Comput. Phys. 1976, 22(4):403-434.
26. Kaminski J.M., Summers J.B., Ward M.B., Huber M.R., Minev B. Immunotherapy and prostate cancer. Cancer Treat. Rev. 2004, 29:199-209.
27. Kennedy B.J. Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy. Blood 1970, 35:751-760.
28. Kirschner D., Panetta J.C. Modeling immunotherapy of the tumour-immune interaction. J. Math. Biol. 1998, 37:235-252.
29. Kirschner D., Arciero J.C., Jackson T.L. A mathematical model of tumor-immune evasion and siRNA treatment. Discr. Cont. Dyn. Syst. 2004, 4:39-58.
30. Kirschner D., Tsygvintsev A. On the global dynamics of a model for tumor immunotherapy. Math. Biosci. Eng. 2009, 6(3):573-583.
31. Krikorian J.G. Spontaneous regression of non/hodgkin lymphoma: a report of nine cases. Cancer 1980, 46:2093-2099.
32. Kronik N., Kogan Y., Vainstein V., Agur Z. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics. Cancer Immunol. Immunother. 2008, 57:425-439.
33. Kuznetsov K.A., Knott G.D. Modeling tumour regrowth and immunotherapy. Math. Comput. Modelling 2001, 33:1275-1287.
34. Kuznetsov V.A., Makalkin I.A., Taylor M.A., Perelson A.S. Nonlinear dynamics of immunogenic tumours: parameter estimation and global bifurcation analysis. Bull. Math. Biol. 1994, 56:295-321.
35. Lecca, P., 2006. A time-dependent extension of Gillespie algorithm for biochemical stochastic π- calculus. In: Proceedings of the 2006 ACM symposium on Applied Computing, pp. 137-144.
36. Mehta B.C., Agarwal M.B. Cyclic oscillations in leukocyte count in chronic myeloid leukemia. Acta Hematologica 1980, 63:68-70.
37. Nani F., Freedman H.I. A mathematical model of cancer treatment by immunotherapy. Math. Biosci. 2000, 163:159-199.
38. Nasell I. Measles Outbreaks are not Chaotic. Mathematical Approaches for Emerging and Reemerging Infectious Diseases: Models, Methods, and Theory, The IMA Volumes in Mathematics and its Applications 2002, vol. 126:85-114. Springer-Verlag, New York.
39. Pardoll D. Does the immune system see tumours as foreign or self?. Ann. Rev. Immunol. 2003, 21:807-839.
40. Salis H., Kaznessis Y. Accurate hybrid stochastic simulation of a system of coupled chemical or biochemical reactions. J. Chem. Phys. 2005, 122:054103.
41. Sohrabi A., Sandoz J., Spratt J.S., Polk H.C. Recurrence of breast cancer: obesity, tumor size, and axillary lymph node metastases. J. Am. Med. Assoc. 1980, 244(3):264-265.
42. Stepanova N.V. Course of the immune reaction during the development of a malignant tumour. Biophysics 1980, 24:917-923.
43. Szymanska S. Analysis of the immunotherapy models in the context of cancer dynamics. Int. J. Appl. Math. Comput. Sci. 2003, 13:407-418.
44. Tsao H., Cosimi A.B., Sober A.J. Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 1997, 79(12):2361-2370.
45. Vicari A.P., Caux G., Trinchieri G. Tumour escape from immune surveillance through dendritic cell inactivation. Semin. Cancer Biol. 2002, 12:33-42.
46. Vodopick H., Rupp E.M., Edwards C.L., Goswitz F.A., Beauchamp J.J. Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia. New Engl. J. Med. 1972, 286:284-290.
47. Whiteside T.L. Tumour-induced death of immune cells: its mechanisms and consequences. Semin. Cancer Biol. 2002, 12:43-50.